Correction for Melo et al., Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing

Medical sciences: correction for "Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing," by SoniaMelo, Alberto Villanueva, Catia Moutinho, Veronica Davalos, Riccardo Spizzo, Cristina Ivan, Simona Rossi, Fernando S...

Full description

Authors: Melo, Sónia Rita Cardoso, 1978-; Villanueva Garatachea, Alberto; Moutinho, Cátia; Davalos, Veronica; Spizzo, Riccardo; Ivan, Cristina; Rossi, Simona; Setién, Fernando; Casanovas i Ibáñez, Òscar; Simó-Riudalbas, Laia; Carmona, F. Javier; Carrere, Jordi; Vidal-Bel, August; Aytés Meneses, Álvaro; Puertas, Sara; Ropero, Santiago; Kalluri, Raghu; Croce, Carlo M.; Calin, George A.; Esteller, Manel, 1968-
Format: Article
Status:Published version
Publication date:2017
Country:España
Institution:Universidad de Barcelona
Repository:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/179323
Online Access:https://hdl.handle.net/2445/179323
Access Level:Open access
Keyword:Càncer
Micro RNAs
Molècules
Cancer
MicroRNAs
Molecules
Summary:Medical sciences: correction for "Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing," by SoniaMelo, Alberto Villanueva, Catia Moutinho, Veronica Davalos, Riccardo Spizzo, Cristina Ivan, Simona Rossi, Fernando Setien, Oriol Casanovas, Laia Simo-Riudalbas, Javier Carmona, Jordi Carrere, August Vidal, Alvaro Aytes, Sara Puertas, Santiago Ropero, Raghu Kalluri, Carlo M. Croce, George A. Calin, and Manel Esteller, which appeared in issue 11, March 15, 2011, of Proc Natl Acad Sci USA (108:4394-4399; first published February 28, 2011; 10.1073/pnas.1014720108).

Similar Items